Selected data models

You must log in to select data models for download or further analysis.

6 Search results.
Relevance Rating New first Old first

Baseline Laboratory test form pancreatic cancer SWOG S0205 NCT00075686

- 9/24/15 - 1 form, 2 itemgroups, 35 items, 1 language
Itemgroups: Header, BASELINE LAB TEST RESULTS
BASELINE LABORATORY TEST RESULT FORM - 2307541v3.0 SOUTHWEST ONCOLOGY GROUP S0205 BASELINE LABORATORY TEST RESULT FORM S0205 Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F2FD3D46-E071-663C-E034-0003BA3F9857

On-Study - Curative Treatment for Head and Neck Cancer - On-Study Form - 2268312v3.0 - Curative Treatment for Head and Neck Cancer - On-Study Form

- 9/20/21 - 1 form, 5 itemgroups, 48 items, 1 language
Itemgroups: CRF Header, Head & Neck: Form Administration, Head & Neck: Patient Assessment, Head & Neck: Disease Description, Head & Neck: Prior Health History - Curative
Curative Treatment for Head and Neck Cancer - On-Study Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D4976276-569A-5CEB-E034-0003BA12F5E7

SOUTHWEST ONCOLOGY GROUP S0205 BASELINE PHYSICAL EXAMINATION FORM NCT00075686

- 9/20/21 - 1 form, 2 itemgroups, 23 items, 1 language
Itemgroups: Header, Physical examination
SOUTHWEST ONCOLOGY GROUP S0205 BASELINE PHYSICAL EXAMINATION FORM NCT00075686 S0205 Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F2FD44E4-4DFA-66A0-E034-0003BA3F9857

SOUTHWEST ONCOLOGY GROUP (S0205) BASELINE TUMOR ASSESSMENT FORM NCT00075686

- 6/12/15 - 1 form, 4 itemgroups, 20 items, 1 language
Itemgroups: Header, Target lesion status, Diagnostic Test, COMMENTS
SOUTHWEST ONCOLOGY GROUP (S0205) BASELINE TUMOR ASSESSMENT FORM NCT00075686 S0205 Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F2EA530F-C48C-139C-E034-0003BA3F9857

Baseline Disease Evaluation Form (RECIST) NCT00058149

- 6/3/15 - 1 form, 5 itemgroups, 21 items, 1 language
Itemgroups: ECOG clinical trial administrative data, TARGET LESIONS:, NONTARGET LESIONS:, Comments, CCRR MODULE
Baseline Disease Evaluation Form (RECIST) NCT00058149 A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A6277560-71F5-3D77-E034-0003BA0B1A09

ECOG Baseline Disease Evaluation Form (RECIST) NCT00057876

- 6/3/15 - 1 form, 5 itemgroups, 22 items, 1 language
Itemgroups: ECOG clinical trial administrative data, TARGET LESIONS, NONTARGET LESIONS, Comments, CCRR MODULE
ECOG Baseline Disease Evaluation Form (RECIST) NCT00057876 Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A62322A5-CF54-3B58-E034-0003BA0B1A09

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial